Foshan Fosun Chancheng Hospital｜“Do You Need Lifelong Medication for Diabetes?” Biomarker Changes in One Patient after 3‑Month Metabolic Intervention
After being diagnosed with Type 2 diabetes, many people assume they will have to take medicine for the rest of their lives. The experience of Mr. Chen may offer a valuable reference. At the Medical Weight‑Loss & Diabetes‑Obesity Remission Center of Foshan Fosun Chancheng Hospital, he received systematic metabolic intervention for three months, resulting in improvements in multiple indicators including body weight, blood glucose and fatty liver.
More Medications, Yet Harder‑to‑Control Blood Glucose
Mr. Chen, 45 years old, was diagnosed with Type 2 diabetes one year ago. He took oral anti‑diabetic drugs as instructed, yet his blood glucose remained poorly controlled. At initial consultation, his fasting blood glucose stood at 9.42 mmol/L and 2‑hour post‑prandial glucose reached 15.95 mmol/L, both above normal ranges. Physical examination also detected moderate fatty liver and hyperlipidemia.
In addition, he experienced blurred vision after prolonged eye use, which may be linked to microvascular changes triggered by high blood glucose. Without long‑term glycemic control, he faced risks of progressing to diabetic retinopathy.
He had tried self‑directed weight loss including dieting, physical exercise and various online regimens. Without professional guidance, however, he struggled with adherence and saw fluctuating outcomes. “I kept taking medicines, while my blood glucose rose and complication risks mounted.” He suffered severe anxiety during that period.
Beyond Blood Glucose: Holistic Assessment of Metabolic Disorders
When first admitted to the center, Mr. Chen weighed 87.3 kg with a waist circumference of 100.5 cm and a BMI of 28.2, indicating obvious abdominal obesity. The expert panel identified that his core issue was a vicious metabolic cycle driven by abdominal obesity:
Abdominal obesity → aggravated insulin resistance → uncontrolled blood glucose → increased medication dosage → further weight gain → onset of complications
These factors interact with one another. Simply adjusting anti‑diabetic medicines only modifies glucose readings without addressing upstream triggers such as obesity, poor dietary patterns and insufficient physical activity. Visceral fat releases free fatty acids and inflammatory mediators that interfere with insulin signalling. Fatty liver, closely associated with insulin resistance, impairs hepatic glucose regulation. Blurred vision represents an early sign of microvascular injury from hyperglycemia. Obesity, hyperglycemia and fatty liver are often not separate illnesses but different manifestations of shared metabolic disturbance.
Multidisciplinary Whole‑Process Management: Individualized Intervention Protocol
Adopting the “5+N” remission therapy, the Diabetes‑Obesity Remission Center formulates personalized plans for each patient.
Comprehensive assessment and precise profiling
Endocrinologists performed systematic evaluations for Mr. Chen, including blood glucose, glycated hemoglobin, lipid panel, liver function, visceral fat area and insulin release test, to identify key bottlenecks of his metabolic disorder.
Nutritional intervention: science without starvation
Based on his body weight, metabolic status and lifestyle, dietitians designed a phased medical nutrition therapy. Instead of eating less, the focus lies on eating properly. By adjusting nutrient ratios and meal sequence, a reasonable calorie deficit is achieved while maintaining satiety.
Exercise prescription tailored for middle‑aged adults
Health managers customized exercise regimens dominated by moderate‑to‑low‑intensity aerobic training, with progressive resistance training, fully considering his age, physical fitness baseline and joint conditions.
Ongoing follow‑up and dynamic adjustment
Over three months, physicians re‑evaluated metabolic markers at regular intervals; dietitians reviewed dietary compliance weekly; health coaches guided daily exercise. The team modified the protocol whenever plateau phases or dietary challenges occurred.
“Physicians, dietitians and health coaches provided continuous support. I did not have to starve myself, and the exercise plan suited middle‑aged people. I could reach out whenever problems arose — I never wanted to give up.”
How Can Metabolic Intervention Achieve Diabetes Remission?
Multiple recent clinical studies indicate that for patients with obesity‑related Type 2 diabetes of relatively short duration, systematic metabolic intervention may lead to diabetes remission. That means blood glucose stays within normal ranges even after discontinuing anti‑diabetic medication, supported by solid scientific evidence.
Weight loss improves insulin sensitivity: Visceral fat is a major driver of insulin resistance. Weight reduction reduces visceral fat mass and may restore insulin sensitivity in liver and muscle tissues.
Alleviation of lipotoxicity: Fatty liver arises from excessive lipid accumulation within hepatocytes. Weight loss plus nutritional intervention lowers intrahepatic fat and helps recover hepatic glucose metabolism.
Therapeutic window for early intervention: In early‑stage Type 2 diabetes, pancreatic β‑cells retain substantial recovery potential. Timely intervention relieves metabolic burden before irreversible functional decline sets in.
Multidisciplinary care outperforms single‑modality treatment: Medications mainly target glucose levels, while metabolic intervention addresses root factors such as obesity, poor diet and sedentary behaviour. Integrated management improves metabolic disturbance across multiple pathways.
Diabetes Remission Is Not Cure
It must be emphasized: diabetes remission ≠ cure. Any medication adjustment shall be conducted strictly under physician supervision. Sustained lifestyle modification is required to maintain favourable metabolic status. Intervention plans must be individualized according to each patient’s profile, and eligibility for metabolic intervention shall be assessed by qualified medical practitioners.
Comments